Browsing IQS by Subject "B-NHL"
Now showing items 1-1 of 1
-
Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma
(Journal of Hematology & Oncology. Vol.10, n.80 (2017), 2017-03)Background Pharmacological inhibition of B cell receptor (BCR) signaling has recently emerged as an effective approach in a wide range of B lymphoid neoplasms. However, despite promising clinical activity ...